A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension

Clinical trial NCT06872112 · RECRUITING

Trial details

NCT number: NCT06872112
Sponsor: Joseph C. Wu
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension (PAH)

Start date: 2026-04-01
Primary completion: 2029-01-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.